How much is the total cost of using Icoritumab for one year?
Epcoritumab (Epcoritamab), as a new type of immunotherapy, has significant therapeutic effects, but its treatment cost is also relatively high. The cost of icarelatumumab treatment is affected by many factors, including the patient's treatment plan, drug pricing in the region, and medical insurance coverage. Generally, icorituzumab is relatively expensive overseas, with the price of the original drug ranging from $1,000 to more than $10,000 per box, making it a high-cost treatment option.
In the United States, the price of icorelatumumab may vary depending on the purchase channel, and a box usually sells for several thousand to ten thousand dollars. For some patients who require long-term treatment, the total cost of treatment will be calculated based on the medication cycle and dose per cycle, and the total annual cost may reach tens of thousands of dollars. In addition, because the drug is mainly suitable for patients with lymphoma who have relapsed or been refractory after multiple lines of treatment, some patients may need to use the drug for a long time, which further increases the overall cost of treatment.
Although icorituzumab is more expensive, its therapeutic efficacy is excellent in relapsed or refractory lymphoma (non-Hodgkin lymphoma). Many patients can significantly extend progression-free survival (PFS) and improve their quality of life after taking this drug. For patients with a heavy financial burden, some insurance plans may cover the cost of treatment, especially in countries such as the United States, where patients can obtain certain cost support through medical insurance or pharmaceutical assistance programs.
The cost of treatment with icorituzumab is relatively high, and the annual treatment cost may reach tens of thousands of dollars. Prices are affected by region and health insurance coverage, and some patients may be able to get help through insurance or assistance programs.
Reference materials:https://www.drugs.com/epcoritamab.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)